<H1>Chapter DOI: 10.1007/s00105-014-3577-6<br/>Cited-By Count: 1</H1><table border="1" width="30%"><tr><td>Total References</td><td>16</td></tr><tr><td>Springer references</td><td>2</td></tr><tr><td>Non Springer references</td><td>14</td></tr><tr><td>BibStructured Count</td><td width="10%">11</td></tr><tr><td>BibUnstructured Count</td><td width="10%">5</td></tr><tr><td>DOI already available in SpringerLink</td><td>10</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>0</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>Commission Communication 697</span> to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Rare Diseases: Europe&#8217;s Challenges 11 Nov. <span style='background:#66FF66'>2008</span></td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibUnstructured</td><td>Regulation (EC) No. 141/<span style='background:#66FF66'>2000</span> <span style='background:#FFFF0F'>of the European Parliament and of the Council of 16 Dez. 1999 on orphan medicinal products</span></td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>Commission Communication 697</span> European Council. Council Recommendation on an action in the field of rare diseases (2009/C 151/02), 08 Juni <span style='background:#66FF66'>2009</span></td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Von Hoff DD, LoRusso PM, Rudin CM et al (2009) Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 361(12):1164&#8211;1172</td><td><a href=http://dx.doi.org/10.1056/NEJMoa0905360>10.1056/NEJMoa0905360</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Cicardi M, Banerji A, Bracho F et al (2010) Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 363(6):532&#8211;541</td><td><a href=http://dx.doi.org/10.1056/NEJMoa0906393>10.1056/NEJMoa0906393</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Wally V, Kitzmueller S, Lagler F et al (2013) Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study. Orphanet J Rare Dis 8:69. doi:10.1186/1750-1172-8-69</td><td><a href=http://dx.doi.org/10.1186/1750-1172-8-69>10.1186/1750-1172-8-69</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Bruckner-Tuderman L, McGrath JA, Robinson EC, Uitto J (2012) Progress in epidermolysis bullosa research: summary of DEBRA international research conference. J Invest Dermatol 133(9):2121&#8211;2126</td><td><a href=http://dx.doi.org/10.1038/jid.2013.127>10.1038/jid.2013.127</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Fine JD (2010) Inherited epidermolysis bullosa. Orphanet J Rare Dis 5:12</td><td><a href=http://dx.doi.org/10.1186/1750-1172-5-12>10.1186/1750-1172-5-12</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, Marinkovich MP, Martinez AE, McGrath JA, Mellerio JE, Moss C, Murrell DF, Shimizu H, Uitto J, Woodley D, Zambruno G (2014) Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 70(6):1103&#8211;1126</td><td><a href=http://dx.doi.org/10.1016/j.jaad.2014.01.903>10.1016/j.jaad.2014.01.903</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Castiglia D, Zambruno G (2010) Molecular testing in epidermolysis bullosa. Dermatol Clin 28(2):223&#8211;229</td><td><a href=http://dx.doi.org/10.1016/j.det.2009.12.003>10.1016/j.det.2009.12.003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>O&#322;dak M, Kowalewski C, Maksym RB, Wo&#378;niak K, Pollak A, Podg&#243;rska M, Wnorowski A, Kosi&#324;ska J, P&#322;oski R (2010) Novel keratin 14 hotspot mutation in Dowling-Meara type of epidermolysis bullosa simplex: strategy to avoid KRT14 pseudogene amplification by a simple approach. J Dermatol Sci 57(1):69&#8211;70</td><td><a href=http://dx.doi.org/10.1016/j.jdermsci.2009.09.006>10.1016/j.jdermsci.2009.09.006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Yuan H, Liu F, Xiao B, He Y, Liang Y, Liu J (2008) Mutation screening of entire keratin 5 and keratin 14 genes and identification of a novel mutation in a Chinese family with epidermolysis bullosa simplex Dowling-Meara. J Eur Acad Dermatol Venereol 22(12):1510&#8211;1512</td><td><a href=http://dx.doi.org/10.1111/j.1468-3083.2008.02687.x>10.1111/j.1468-3083.2008.02687.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Neveling K, Hoischen A (2012) Exom-Sequenzierung zur Identifikation von Krankheitsgenen. Med Gen 24:4&#8211;11</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR14</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>&#214;sterreichische</span> <span style='background:#DDDDDD'>Bundesregierung</span></span></aug> (<span style='background:#66FF66'>1998</span>) <span style='background:#FFD9B3'>&#196;nderung des Gentechnikgesetzes, GTG</span> . BGBL I: 73/1998</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibUnstructured</td><td>Bundesgesetzblatt Teil 1 Nr. 58/2011 vom 24. Nov. 2011, S.&amp;nbsp;2228, FNA: 453-19; EAPl 500/neu 5000</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Castori M, Floriddia G, Pisaneschi E, Covaciu C, Paradisi M, Torrente I, Castiglia D (2008) Complete maternal isodisomy causing reduction to homozygosity for a novel LAMB3 mutation in Herlitz junctional epidermolysis bullosa. J Dermatol Sci 51:58&#8211;61</td><td><a href=http://dx.doi.org/10.1016/j.jdermsci.2008.02.006>10.1016/j.jdermsci.2008.02.006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>